Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
F Cai, MAF Luis, X Lin, M Wang… - Molecular and …, 2019 - spandidos-publications.com
Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of
malignancies. Cardiotoxicity is a well‑recognized side effect of anthracycline therapy that …
malignancies. Cardiotoxicity is a well‑recognized side effect of anthracycline therapy that …
Valproic acid and breast cancer: State of the art in 2021
A Wawruszak, M Halasa, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most common cancer diagnosed among women
worldwide. Despite numerous studies, the pathogenesis of BC is still poorly understood, and …
worldwide. Despite numerous studies, the pathogenesis of BC is still poorly understood, and …
Estrogen receptor signaling as a target for novel breast cancer therapeutics
JM Renoir, V Marsaud, G Lazennec - Biochemical pharmacology, 2013 - Elsevier
In breast cancer (BC) epithelial cells, the mitogenic action of estradiol is transduced through
binding to two receptors, ERα and ERβ, which act as transcription factors. Anti-estrogens …
binding to two receptors, ERα and ERβ, which act as transcription factors. Anti-estrogens …
Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA
J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
Epigenetic regulation in breast cancer: Insights on epidrugs
A Kim, K Mo, H Kwon, S Choe, M Park, W Kwak… - Epigenomes, 2023 - mdpi.com
Breast cancer remains a common cause of cancer-related death in women. Therefore,
further studies are necessary for the comprehension of breast cancer and the revolution of …
further studies are necessary for the comprehension of breast cancer and the revolution of …
The histone acetylation modifications of breast cancer and their therapeutic implications
P Guo, W Chen, H Li, M Li, L Li - Pathology & Oncology Research, 2018 - Springer
The histone acetylation modifications (HAMs) influence a large number of cellular functions.
They are mediated through histone acetyltransferase (HAT) and histone deacetylase …
They are mediated through histone acetyltransferase (HAT) and histone deacetylase …
DNA methylation pattern as important epigenetic criterion in cancer
M Ghavifekr Fakhr, M Farshdousti Hagh… - Genetics research …, 2013 - Wiley Online Library
Epigenetic modifications can affect the long‐term gene expression without any change in
nucleotide sequence of the DNA. Epigenetic processes intervene in the cell differentiation …
nucleotide sequence of the DNA. Epigenetic processes intervene in the cell differentiation …
Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1
Transcriptional regulation of ESR1, the gene that encodes for estrogen receptor α (ER), is
critical for regulating the downstream effects of the estrogen signaling pathway in breast …
critical for regulating the downstream effects of the estrogen signaling pathway in breast …
Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview
D Büsselberg, AM Florea - Cancers, 2017 - mdpi.com
Cancer is a main public health problem all over the world. It affects millions of humans no
matter their age, gender, education, or social status. Although chemotherapy is the main …
matter their age, gender, education, or social status. Although chemotherapy is the main …
Estrogen receptor α revised: Expression, structure, function, and stability
M Habara, M Shimada - Bioessays, 2022 - Wiley Online Library
Estrogen receptor α (ERα) is a ligand‐dependent transcription factor that regulates the
expression of estrogen‐responsive genes. Approximately 70% of patients with breast cancer …
expression of estrogen‐responsive genes. Approximately 70% of patients with breast cancer …